Tesamorelin 20mg
Stabilised GHRH analogue (trans-3-hexenoyl-GRF 1-44)
≥99.0%
Third-Party
COA
Also available in 5mg · 10mg — compare all sizes
Complete your research kit
Also searched as: TH9507
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
Tesamorelin 20mg is a lyophilised peptide preparation supplied as a laboratory research material. The compound is an analogue of human growth hormone-releasing hormone (GHRH) and has been investigated for its role in GHRH receptor signalling and regulation of the growth hormone axis. The 20mg presentation offers a higher nominal vial quantity for Australian research settings where experimental designs require a larger amount of the same single peptide. It is intended exclusively for scientific and analytical applications.
What Is Tesamorelin 20mg?
Tesamorelin belongs to the GHRH analogue class of research peptides. Its 44-amino-acid structure is related to naturally occurring human GHRH but incorporates a structural modification associated with improved resistance to enzymatic degradation.
Its primary biological target is the growth hormone-releasing hormone receptor (GHRHR). Interaction with this receptor initiates intracellular signalling in pituitary somatotroph cells, which are responsible for growth hormone production and secretion.
This defined receptor interaction has made Tesamorelin useful for experimental investigation of endocrine signalling and the regulation of the GH axis.
Key Research Areas
Why Researchers Study Tesamorelin 20mg
Tesamorelin provides researchers with an established molecular target: GHRHR. This makes it useful when an experimental design requires investigation of receptor-mediated regulation rather than direct exposure to growth hormone itself.
Another point of interest is the relationship between initial receptor activation and subsequent biological signals. Researchers can examine GHRHR activity alongside changes occurring further downstream within the GH and IGF-1 pathways.
The 20mg presentation changes the quantity of research material supplied, not the fundamental molecular identity or mechanism of Tesamorelin. Experimental requirements should therefore determine which vial quantity is appropriate for a particular laboratory project.
Key Research Areas at a Glance
Tesamorelin 20mg in Australia
Australian laboratories considering Tesamorelin 20mg should evaluate the product using factors such as batch traceability, analytical documentation, vial specification and research-use labelling.
When comparing Tesamorelin 20mg online Australia options, researchers can check the current Tesamorelin 20mg price, stock position, availability of a batch CoA and domestic dispatch information before placing an order.
The 20mg format is a quantity option for research requirements and should not be interpreted as a dosage or administration recommendation.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Tesamorelin 20mg is presented as lyophilised material with a nominal peptide quantity of 20mg per vial.
Batch-level analytical information should be reviewed when assessing research material. Depending on the testing undertaken, documentation may provide information about peptide identity, purity and other analytical characteristics.
Researchers should refer to the Certificate of Analysis (CoA), where available, to determine the actual methods and results associated with a particular batch. HPLC or mass spectrometry should only be claimed for the product when confirmed by its analytical documentation.
Purity measurements characterise the material and do not establish suitability for human or therapeutic use.
Storage & Handling
Storage and Laboratory Handling
- Unreconstituted Material: Maintain Tesamorelin 20mg according to the verified storage conditions accompanying the product and its batch documentation.
- Following Reconstitution: Use conditions supported by validated laboratory procedures or specific stability documentation.
Storage temperatures, reconstitution volumes and stability periods should not be assumed where they have not been verified for the material concerned.
Reconstitution calculator: Tesamorelin 20mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
Tesamorelin 20mg: Frequently Asked Questions
It contains a nominal 20mg quantity of Tesamorelin supplied as lyophilised research material.
Yes. Tesamorelin is structurally related to human GHRH and is studied for its interaction with GHRH receptors.
Receptor activation initiates signalling associated with pituitary somatotroph activity and regulation of growth hormone secretion.
Growth hormone influences IGF-1 production, making downstream IGF-1 signalling relevant when investigating the broader GH axis.
No. The 20mg designation describes the nominal quantity supplied per vial rather than a different Tesamorelin molecule.
Review the relevant CoA and analytical documentation for confirmed identity, purity and testing information.
Laboratories should follow verified product and batch documentation rather than applying unsupported storage or stability assumptions.
Researchers can check Australian research peptide suppliers for current stock, pricing, batch documentation and domestic shipping information.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
Tesamorelin is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.